Answers are grounded in this paper and cite their sources.
• While there has been significant investment in developing Bifidobacteria-based probiotics, the direct mechanisms underlying these beneficial effects have been challenging to elucidate. Here, we investigated how a human gut isolate Bifidobacterium longum 1714 could impact the immune system and identified the mechanisms employed by the strain for this interaction. Importantly, more than one mechanism was shown to influence host immune responses. Intrinsic properties of the B. longum 1714 cell wall, its EPS, and its ability to generate and metabolize tryptophan provide complementary mechanisms that contribute to the ability of this bacterium to reduce peripheral inflammation. Specific bifidobacterial strains can reduce aberrant inflammatory responses, but the strain-specific factors that promote regulatory immune responses are not well elucidated. The aims of this study were to assess the effects of Bifidobacterium longum 1714™ on innate inflammatory responses and to identify the strain-associated features that mediate its immunomodulatory effects. B. longum 1714 induced peripheral blood mononuclear cell (PBMC) and monocyte derived dendritic cell (MDDC) cytokine secretion and costimulatory molecule expression in a strain specific manner. B. longum 1714 consumption reduced excessive cytokine responses in LPS-induced, stress-induced and obesity-induced inflammation in murine models. B. longum 1714 produced a branched hexasaccharide repeating unit exopolysaccharide (EPS), which selectively induced PBMC secretion of IL-10. Furthermore, B. longum 1714 produced tryptophan and indole lactic acid (ILA) in vitro , and ILA directly reduced TLR-induced proinflammatory cytokine secretion and NF-κB activation. Finally, increased plasma levels of tryptophan and kynurenic acid were identified in humans following B. longum 1714 consumption. B. longum 1714 influences the immune system through intrinsic features associated with strain specific surface EPS and via secreted metabolic products, which demonstrates the potential for multiple mechanisms through which a specific probiotic may modulate immune responses and potential neuroprotective pathways.
No takes yet. Share an insight, caveat, or question.
Groeger et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: